CTIBiotech products

The Ex vivo kit from CTISkin® is a standardised and ready to use solution for your efficacy and safety tests. Collected just after the surgical intervention, we provide you with the freshest possible skin biopsies. According to the declaration of Helsinki, all skin samples are collected with donors informed consent and tested for HIV, HCV and HBC to ensure a negative serotyping. Provided with adapted culture medium, those biopsies can be used up to 11 days after the surgical resection. We can provide you regulary with fresh Ex Vivo skin.

CTISkin® Single Donor Kit provides you with up to 6 different primary cell types from one single donor to reduce biological variations in your in vitro / tissue engineering assays. All kits are provided with defined cell culture media suitable for each specific cell type and recommended protocol as a turnkey solution for your safety or efficacy tests.

Using the latest tools in bioengeneering, our researchers are now printing cancer tissues in 3D. These models can be used for highly significant pre-clinical trials and can be produced in 6/48/96 well plates for high throughput screening.

Use of our 1 000 m² state of the art R&D facilities with access to CTIBiosourcing and a highly trained team of international researchers located just 10 minutes from Lyon International Airport.

Test your active ingredients, cosmetics, and dermatology products on advanced models and add credibility to substantiate efficiency claims for discerning customers. Donors can be selected by gender, age, phototype.

Since the 1980’s researchers at CTIBIOTECH have always been at the forefront of what is now called Regenerative Medicine. Experts in harvesting, manipulation, differentiation and development of human tissues from stem cell and progenitor cell tissues, they have published widely in this field, been involved in clinical trials and patented commercially available work.

Bioassay Development and toxicology screening: The cell production and differentiation expertise of CTIBIOTECH has been applied to creating unique and sensitive toxicology and drug-response bioassays in conjunction with major pharmaceutical actors.

CTIBIOTECH has strong partners in dermatology having developed key assays and technologies to evaluate skin cell responsiveness.

CTIBIOTECH is one of the few SME companies in Europe licensed as a human tissue/cell biobank. The CTIBIOBANK stores cells and tissues which are used internally and with our partners.